Relationship between pulse pressure and Fibrosis-4 score in non-drinking Korean adults using the Korea National Health and Nutrition Examination Survey

• Ju Ae Cha ^[2] ; Mi Young Gi ^[3] ; Hyun Yoon ^[1]
  1. [1] WonKwang Health Science University

     WonKwang Health Science University

     Corea del Sur

     
  2. [2] Chunnam Technouniversity
  3. [3] Christian College of Nursing

  Mostrar afiliaciones +
• Localización: Nutrición clínica y dietética hospitalaria, ISSN 0211-6057, Vol. 45, Nº. 2, 2025, págs. 289-297
• Idioma: inglés
• DOI: 10.12873/452yoon
• Enlaces
  • Texto completo
• Resumen

  • Background: The present study was conducted to assess the association between fibrosis-4 score (FIB-4) and pulse pressure (PP) in Korean adults.

    Materials and Methods: Data on 4,236 adults aged 20 or older were obtained from the 2020 Korean National Health and Nutrition Examination Survey.

    Results: There were several key findings in the present study. First, compared with the quartile 1 (Q1) of FIB-4, the odds ratio (OR) of high PP (PP > 60 mmHg) was significantly higher in Q2 (OR, 3.469; 95% confidence interval [CI], 1.737–6.928), Q3 (OR, 7.256; 95% CI, 3.744–14.061), and Q4 (OR, 16.660; 95% CI, 8.671–32.007). Second, for predicting high PP, the receiver-operating characteristic (ROC) curve analysis for FIB-4 (area under the ROC curve [AUC], 0.787; 95% CI, 0.769–0.804; p < 0.001). In addition, FIB-4 was superior to other non-invasive hepatic fibrosis indices, such as the aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio (z = 11.857; p < 0.001) or AST/platelet ratio index (z = 10.024; p < 0.001) for predicting high PP Conclusions: FIB-4 was positively associated with PP and SBP in Korean adults but was inversely associated with DBP. In addition, FIB-4 was superior to other non-invasive hepatic fibrosis indices for predicting high PP.

• Referencias bibliográficas
  • Litwin M, Obrycki Ł, Niemirska A, Sarnecki J, Kułaga Z. Central systolic blood pressure and central pulse pressure predict left ventricular...
  • Homan TD, Bordes S, Cichowski E. Physiology, Pulse Pressure. [Updated 2022 Jul 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls...
  • Liu D, Qin P, Liu L, Liu Y, Sun X, Li H, Zhao Y, Zhou Q, Li Q, Guo C, Tian G, Wu X, Han M, Qie R, Huang S, Zhang M, Hu D, Lu J. Association...
  • Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee...
  • Le MH, Yeo YH, Li X, Li J, Zou B, Wu Y, Ye Q, Huang DQ, Zhao C, Zhang J, Liu C, Chang N, Xing F, Yan S, Wan ZH, Tang NSY, Mayumi M, Liu X,...
  • Zisser A, Ipsen DH, Tveden-Nyborg P. Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis-Roles as Putative Treatment Targets?...
  • Kumar R, Priyadarshi RN, Anand U. Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations. J Clin Transl Hepatol....
  • Fierbinteanu-Braticevici C, Purcarea M. Non-biopsy methods to determine hepatic fibrosis. J Med Life. 2009;2:401–406. PMID: 20108754.
  • Taniguchi T, Sakata Y, Ohtani T, Mizote I, Takeda Y, Asano Y, Masuda M, Minamiguchi H, Kanzaki M, Ichibori Y, Nishi H, Toda K, Sawa Y, Komuro...
  • Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, S Sulkowski M, Torriani FJ, Dieterich DT, Thomas DL, Messinger D, Nelson...
  • McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis...
  • Hagström H, Nasr P, Ekstedt M, Stål P, Hultcrantz R, Kechagias S. Accuracy of Noninvasive Scoring Systems in Assessing Risk of Death and Liver-Related...
  • Kim SW, Jeon JH, Moon JS, Kim MK. High Fibrosis-4 Index Is Related with Worse Clinical Outcome in Patients with Coronavirus Disease 2019 and...
  • Jaruvongvanich V, Wirunsawanya K, Sanguankeo A, Upala S. Nonalcoholic fatty liver disease is associated with coronary artery calcification:...
  • Lee J, Kim HS, Cho YK, Kim EH, Lee MJ, Bae IY, Jung CH, Park JY, Kim HK, Lee WJ. Association between noninvasive assessment of liver fibrosis...
  • Thévenot T, Vendeville S, Weil D, Akkouche L, Calame P, Canivet CM, Vanlemmens C, Richou C, Cervoni JP, Seronde MF, Di Martino V, Boursier...
  • Nam GE, Kim YH, Han K, Jung JH, Rhee EJ, Lee SS, et al. Obesity Fact Sheet in Korea, 2019: Prevalence of Obesity and Abdominal Obesity from...
  • Seong JM, Lee JH, Gi MY, Son YH, Moon AE, Park CE, Sung HH, Yoon H. Gender difference in the association of chronic kidney disease with visceral...
  • Sung HH, Gi MY, Cha JA, Cho HE, Moon AE, Yoon H. Gender difference in the relationship between lipid accumulation product index and pulse...
  • Wang HW, Peng CY, Lai HC, Su WP, Lin CH, Chuang PH, Chen SH, Chen CH, Hsu WF, Huang GT. New noninvasive index for predicting liver fibrosis...
  • Ostovaneh MR, Ambale-Venkatesh B, Fuji T, Bakhshi H, Shah R, Murthy VL, Tracy RP, Guallar E, Wu CO, Bluemke DA, Lima JAC. Association of Liver...
  • Stundiene I, Sarnelyte J, Norkute A, Aidietiene S, Liakina V, Masalaite L, Valantinas J. Liver cirrhosis and left ventricle diastolic dysfunction:...
  • Dogan S, Celikbilek M, Yilmaz YK, Sarikaya S, Zararsiz G, Serin HI, Borekci E, Akyol L, Pirti I, Davarci SE. Association between liver fibrosis...
  • Mantovani A, Ballestri S, Lonardo A, Targher G. Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease. Dig...
  • Sibal L, Agarwal SC, Home PD, Boger RH. The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease....
  • Sarmah N, Nauli AM, Ally A, Nauli SM. Interactions among Endothelial Nitric Oxide Synthase, Cardiovascular System, and Nociception during...
  • Pasarín M, Abraldes JG, Liguori E, Kok B, La Mura V. Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of...